{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:04:15Z","timestamp":1778565855285,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81770330"],"award-info":[{"award-number":["81770330"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).<\/jats:p>\n            <jats:p>The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine\/hydroxychloroquine (CQ\/HCQ), lopinavir\/ritonavir (LPV\/r), quinolones, interferon, Arbidol, or Qingfei Paidu decoction (QPD) and received at least 1 electrocardiogram after drug administration.<\/jats:p>\n            <jats:p>Fifty one (12.9%) patients exhibited QTc prolongation (QTc\u200a\u2265\u200a470\u200ams). QTc interval prolongation was associated with COVID-19 severity and mortality (both <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Administration of CQ\/HCQ (odds ratio [OR], 2.759; 95% confidence interval [CI], 1.318\u20135.775; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.007), LPV\/r (OR, 2.342; 95% CI, 1.152\u20134.760; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.019), and quinolones (OR, 2.268; 95% CI, 1.171\u20134.392; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.015) increased the risk of QTc prolongation. In contrast, the administration of Arbidol, interferon, or QPD did not increase the risk of QTc prolongation. Notably, patients treated with QPD had a shorter QTc duration than those without QPD treatment (412.10 [384.39\u2013433.77] vs 420.86 [388.19\u2013459.58]; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.042). The QTc interval was positively correlated with the levels of cardiac biomarkers (creatine kinase-MB fraction [rho\u200a=\u200a0.14, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.016], high-sensitivity troponin I [rho\u200a=\u200a.22, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001], and B-type natriuretic peptide [rho\u200a=\u200a0.27, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001]).<\/jats:p>\n            <jats:p>In conclusion, QTc prolongation was associated with COVID-19 severity and mortality. The risk of QTc prolongation was higher in patients receiving CQ\/HCQ, LPV\/r, and quinolones. QPD had less significant effects on QTc prolongation than other antiviral agents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026538","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T21:08:17Z","timestamp":1626296897000},"page":"e26538","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Corrected QT interval in hospitalized patients with coronavirus disease 2019"],"prefix":"10.1097","volume":"100","author":[{"given":"Jiaxing","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongquan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yintu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huili","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2860-7950","authenticated-orcid":false,"given":"Zhijian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","article-title":"QT interval prolongation and the risk of torsades de pointes: essentials for clinicians","volume":"29","author":"Trinkley","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.84.3.1136","article-title":"The long QT syndrome. Prospective longitudinal study of 328 families","volume":"84","author":"Moss","year":"1991","journal-title":"Circulation"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/CCM.0b013e318232db4a","article-title":"High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in practice (QTIP) study","volume":"40","author":"Pickham","year":"2012","journal-title":"Crit Care Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/europace\/euz058","article-title":"QT prolongation predicts short-term mortality independent of comorbidity","volume":"21","author":"Gibbs","year":"2019","journal-title":"Europace"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13054-019-2514-6","article-title":"New-onset QT prolongation is a novel predictor of mortality in critically ill patients","volume":"23","author":"Ding","year":"2019","journal-title":"Crit Care"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcrc.2019.09.014","article-title":"The incidence, predictors and outcomes of QTc prolongation in critically ill patients","volume":"54","author":"Russell","year":"2019","journal-title":"J Crit Care"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug- and non-drug-associated QT interval prolongation","volume":"70","author":"van Noord","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18773\/austprescr.2002.058","article-title":"Drugs and the QTc interval","volume":"25","author":"Jayasinghe","year":"2002","journal-title":"Aust Prescr"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","article-title":"Risk factors for QTc-prolongation: systematic review of the evidence","volume":"39","author":"Vandael","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","volume":"17","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/2048872620922784","article-title":"Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol","volume":"9","author":"Naksuk","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/cpt.1968","article-title":"QT interval prolongation under hydroxychloroquine\/azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection","volume":"108","author":"Bun","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jelectrocard.2006.09.003","article-title":"Electrocardiographic reference ranges derived from 79,743 ambulatory subjects","volume":"40","author":"Mason","year":"2007","journal-title":"J Electrocardiol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.hrthm.2020.06.029","article-title":"Effects of hydroxychloroquine treatment on QT interval","volume":"17","author":"Hooks","year":"2020","journal-title":"Heart Rhythm"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/jcm9092712","article-title":"Prolonged QT interval in SARS-CoV-2 infection: prevalence and prognosis","volume":"9","author":"Farre","year":"2020","journal-title":"J Clin Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2020.1787","article-title":"Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","volume":"5","author":"Bessiere","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2991\/jegh.k.200806.002","article-title":"Clinical characteristics and outcome of hospitalized COVID-19 patients in a MERS-CoV endemic area","volume":"10","author":"Barry","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"R18-20250504","first-page":"84","article-title":"Population-based study of QT interval prolongation in patients with rheumatoid arthritis","volume":"33","author":"Chauhan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejim.2013.02.009","article-title":"Association between high sensitivity c-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis","volume":"24","author":"Lazzerini","year":"2013","journal-title":"Eur J Intern Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2003.11.003","article-title":"Inhibition of herg K+ currents by antimalarial drugs in stably transfected HEK293 cells","volume":"484","author":"Traebert","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/MJT.0b013e3181ad3437","article-title":"HIV protease inhibitors induced prolongation of the QT interval: electrophysiology and clinical implications","volume":"17","author":"Singh","year":"2010","journal-title":"Am J Ther"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.bjp.0706678","article-title":"Mechanism of herg K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin","volume":"147","author":"Alexandrou","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/ijms20061324","article-title":"QT assessment in early drug development: the long and the short of it","volume":"20","author":"Lester","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1200\/JCO.1993.11.10.1906","article-title":"Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer","volume":"11","author":"Schwartz","year":"1993","journal-title":"J Clin Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"108970","DOI":"10.1016\/j.cbi.2020.108970","article-title":"Rosuvastatin and retinoic acid may act as \u2019pleiotropic agents\u2019 against \u03b2-adrenergic agonist-induced acute myocardial injury through modulation of multiple signalling pathways","volume":"318","author":"Sultan","year":"2020","journal-title":"Chem Biol Interact"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12012-011-9129-8","article-title":"Electrocardiographic characterization of rhesus monkey model of ischemic myocardial infarction induced by left anterior descending artery ligation","volume":"11","author":"Yang","year":"2011","journal-title":"Cardiovasc Toxicol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"E791","DOI":"10.1503\/cmaj.200879","article-title":"Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury","volume":"192","author":"Si","year":"2020","journal-title":"CMAJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:40:31Z","timestamp":1746337231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026538"}},"subtitle":["Focus on drugs therapy"],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":28,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026538","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2020-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}